Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
MB02（贝伐单抗生物类似药）与参考贝伐单抗在晚期非小细胞肺癌中的疗效、安全性和免疫原性：一项随机、双盲、III期研究（STELLA）
期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-021-00483-w
Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran; Makharadze, Tamta; Bellala, Ravi Shankar; Charoentum, Chaiyut; Yañez Ruiz, Eduardo P; Fulop, Andrea; Hyder Ali, Irfhan Ali; Syrigos, Kostas; Katgi, Nuran; Lopez Chuken, Yamil Alonso; Rumyana, Ilieva; Reyes-Igama, Jasmin; Costamilan, Rita de Cassia; Del Campo García, Ana; Florez, Amalia; Paravisini, Alexandra; Millan, Susana
